Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07400926
Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
Sponsor: Glaukos Corporation
View on ClinicalTrials.gov
Summary
Clinical in-use observational trial to evaluate the updated inserter for the Travoprost Intracameral implant using the updated inserter (Model G2-TRIO)
Official title: Clinical In-use Observational Trial to Evaluate the Updated Inserter for the Travoprost Intracameral Implant 75 mcg
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
30
Start Date
2025-12-17
Completion Date
2026-07
Last Updated
2026-02-27
Healthy Volunteers
No
Interventions
COMBINATION_PRODUCT
Travoprost
Travoprost intracameral implant, 75mcg administered using the sterile, single-dose updated inserter (Model G2-TRIO)
Locations (1)
Glaukos Investigative Site
Kenosha, Wisconsin, United States